Slingshot Biosciences Onboards Nimisha Srivastava As Its New COO
Slingshot Biosciences recently announced the addition of Nimisha Srivastava, Ph.D., as Chief Operations Officer. Dr. Srivastava brings more than 20 years of experience in nanofluidics, synthetic biology technology development, and operational scale-up, as well as a proven track record of building high-performing technical teams. Dr. Srivastava’s expertise in scaling disruptive technologies will be instrumental in […]
Synplogen collaborates with Ginkgo Bioworks
Synplogen Co., a synthetic biology startup spun out of Kobe University’s Graduate School of Science, Technology and Innovation that provides custom DNA synthesis and Gene Therapy Biofoundry services, and Ginkgo Bioworks, which is building the leading platform for cell programming and biosecurity, today announced that they have entered into a non-binding Memorandum of Understanding (“MOU”). Together, Synplogen […]
